Inherited susceptibility for pediatric cancer.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Journal

• Publication date

  2005-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00130404-200507000-00002PMID 16197716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expert heads a'rolling

  2005cited by this paper
• Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).

  2005cited by this paper
• Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood

  2005cited by this paper
• Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis.

  2004cited by this paper
• Predictive genetic testing for childhood cancer: taking the road less traveled by.

  2004cited by this paper
• The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.

  2004cited by this paper
• Endolymphatic sac tumors in von Hippel-Lindau disease.

  2004cited by this paper
• Differential Grading of Endolymphatic Sac Tumor Extension by Virtue of von Hippel-Lindau Disease Status

  2004cited by this paper
• Retinoblastoma: Revisiting the model prototype of inherited cancer

  2004cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Childs, B., Kinzler, K. W., and Vogelstein, B., eds., 8th ed., McGraw-Hill, New-York, 2001, 7012 p., $550.00)

  2004cited by this paper
• Tumors of the endolymphatic sac in von Hippel-Lindau disease.

  2004cited by this paper
• Lifetime risks of common cancers among retinoblastoma survivors.

  2004cited by this paper
• Juvenile myelomonocytic leukemia.

  2004cited by this paper
• Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.

  2003cited by this paper
• The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.

  2003cited by this paper
• von Hippel-Lindau disease.

  2003cited by this paper
• Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.

  2003cited by this paper
• Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis.

  2003cited by this paper
• NF2: The wizardry of merlin

  2003cited by this paper
• Germ-line mutations in nonsyndromic pheochromocytoma.

  2002cited by this paper
• Differential NF1, p16, and EGFR Patterns by Interphase Cytogenetics (FISH) in Malignant Peripheral Nerve Sheath Tumor (MPNST) and Morphologically Similar Spindle Cell Neoplasms

  2002cited by this paper
• Hereditary paraganglioma targets diverse paraganglia

  2002cited by this paper
• Germ-line mutations in nonsyndromic pheochromocytoma.

  2002cited by this paper
• Loss of NF1 Alleles Distinguish Sporadic from NF1‐Associated Pilocytic Astrocytomas

  2001cited by this paper
• Relative frequency and morphology of cancers in carriers of germline TP53 mutations

  2001cited by this paper
• An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma

  2001cited by this paper
• Multiple Endocrine Neoplasia

  2001cited by this paper
• Malignant peripheral nerve sheath tumors in neurofibromatosis 1.

  2000cited by this paper
• Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.

  2000cited by this paper
• Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects

  2000cited by this paper
• von Recklinghausen's disease and pheochromocytomas.

  1999cited by this paper
• Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.

  1999cited by this paper
• RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)

  1999cited by this paper
• Solitary thyroid nodules in 93 children and adolescents. a 35-years experience.

  1999cited by this paper
• Solitary Thyroid Nodules in 93 Children and Adolescents

  1999cited by this paper
• Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers.

  1999cited by this paper
• Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.

  1999cited by this paper
• Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma.

  1999cited by this paper
• Overview of RB gene mutations in patients with retinoblastoma. Implications for clinical genetic screening.

  1998cited by this paper
• Multiple primary cancers in families with Li-Fraumeni syndrome.

  1998cited by this paper
• Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

  1998cited by this paper
• Somatic mosaicism: a common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis.

  1998cited by this paper
• Germline mutation profile of the VHL gene in von Hippel‐Lindau disease and in sporadic hemangioblastoma

  1998cited by this paper
• Cytogenetic and molecular analysis of a t(1;22)(p36;q11.2) in a rhabdoid tumor with a putative homozygous deletion of chromosome 22

  1998cited by this paper
• A new reciprocal translocation (12;22)(q24.3;q11.2-12) in a malignant rhabdoid tumor of the brain.

  1998cited by this paper
• Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counseling.

  1998cited by this paper
• Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1.

  1998cited by this paper
• Improved detection of germline mutations in the von Hippel‐Lindau disease tumor suppressor gene

  1998cited by this paper
• Mutations of the NF 1 Gene in Children With Juvenile Myelomonocytic Leukemia Without Clinical Evidence of Neurofibromatosis , Type 1

  1998cited by this paper
• Li-Fraumeni syndrome--a molecular and clinical review.

  1997cited by this paper
• The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

  1997cited by this paper
• Predictive testing for retinoblastoma comes of age.

  1997influential reference
• Role of the retinoblastoma protein in the pathogenesis of human cancer.

  1997cited by this paper
• A splicing mutation in RB1 in low penetrance retinoblastoma

  1997cited by this paper
• Genetic transmission of susceptibility to cancer in families of children with soft tissue sarcomas

  1996cited by this paper
• Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. Commentaries

  1996cited by this paper
• Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma.

  1996cited by this paper
• Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.

  1996cited by this paper
• Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.

  1996cited by this paper
• Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.

  1995cited by this paper
• Pheochromocytoma in multiple endocrine neoplasia type 2: European study

  1995cited by this paper
• Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis.

  1995cited by this paper
• Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6‐year follow‐up

  1995cited by this paper
• Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

  1995cited by this paper
• Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.

  1995cited by this paper
• The t(II; 22)(pI5.5; qII.23) in a retroperitoneal rhabdoid tumor also includes a regional deletion distal to CRYBB2 on 22q

  1995cited by this paper
• Pheochromocytoma in multiple endocrine neoplasia type 2: European study. The Euromen Study Group.

  1995cited by this paper
• Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma.

  1994cited by this paper
• Rhabdoid tumor of the kidney with primitive neuroectodermal tumor of the central nervous system: Associated tumors with different histologic, cytogenetic, and molecular findings

  1994cited by this paper
• Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.

  1994cited by this paper
• Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders.

  1994cited by this paper
• High frequency of germline p53 mutations in childhood adrenocortical cancer.

  1994cited by this paper
• Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

  1994cited by this paper
• Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.

  1994cited by this paper
• Neurofibromatosis type 1 and childhood cancer

  1993cited by this paper
• Identification of the von Hippel-Lindau disease tumor suppressor gene.

  1993cited by this paper
• Mortality from second tumors among long-term survivors of retinoblastoma.

  1993cited by this paper
• Renal Neoplasms Mimicking Rhabdoid Tumor of Kidney: A Report from the National Wilms' Tumor Study Pathology Center

  1991cited by this paper
• A simplified scheme for genetic counseling in retinoblastoma.

  1987cited by this paper
• A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

  1986cited by this paper
• Von Recklinghausen neurofibromatosis: II. Incidence of optic gliomata.

  1985cited by this paper
• von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata.

  1984cited by this paper
• Von Recklinghausen neurofibromatosis.

  1981cited by this paper
• Mutation and cancer: statistical study of retinoblastoma.

  1971cited by this paper

• Risk of Childhood Cancer in Children with Congenital Anomalies and Their Impact on Survival: A Population-Based Registry Approach

  2025cites this paper
• Cancer-predisposing germline variants and childhood cancer

  2020cites this paper
• The McGill Interactive Pediatric OncoGenetic Guidelines: An approach to identifying pediatric oncology patients most likely to benefit from a genetic evaluation

  2017influential citation
• Ethical considerations surrounding germline next-generation sequencing of children with cancer

  2017cites this paper
• Childhood tumours with a high probability of being part of a tumour predisposition syndrome; reason for referral for genetic consultation.

  2017cites this paper
• Consultations d’oncogénétique pédiatrique : Quelles indications et quelles pratiques dans un service spécialisé de cancérologie pédiatrique ? Enquête dans le centre spécialisé du CHU de Bordeaux en 2011–2012

  2016cites this paper
• T u mores neonatales congénitas

  2016cites this paper
• Unique Genetic Counseling Considerations in the Pediatric Oncology Setting

  2015cites this paper
• BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk

  2015cites this paper
• Establishing a translational genomics infrastructure in pediatric cancer: the GREAT KIDS experience.

  2015cites this paper
• American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.

  2014cites this paper
• Cancer predisposition in children: genetics, phenotypes & screening

  2014cites this paper
• Quelles indications et quelles pratiques dans un service spécialisé de cancérologie pédiatrique

  2014cites this paper
• Retinoblastoma detected by preschool vision screening using visual-evoked potentials.

  2013cites this paper
• Identification, management, and evaluation of children with cancer-predisposition syndromes.

  2012cites this paper
• Genetic factors in childhood cancer. Associations between tumors in childhood and adulthood, and prevalence of germline TP53 mutations

  2012cites this paper
• Complex Genotype Sarcomas Display Familial Inheritance Independent of Known Cancer Predisposition Syndromes

  2011cites this paper
• Identification of genetic susceptibility to childhood cancer through analysis of genes in parallel.

  2011cites this paper
• Retinoblastoma in a Child After Normal Autorefraction and Traditional Vision Screening

  2011cites this paper
• Reduced mRNA and Protein Expression of the Genomic Caretaker RAD9A in Primary Fibroblasts of Individuals with Childhood and Independent Second Cancer

  2011cites this paper
• Major Radiodiagnostic Imaging in Pregnancy and the Risk of Childhood Malignancy: A Population-Based Cohort Study in Ontario

  2010cites this paper
• Inherited Cancer Syndromes in Children and Young Adults

  2010cites this paper
• [Neonatal tumours and congenital malformations].

  2008cites this paper
• [Risks factors for pediatric malignant liver tumors].

  2008cites this paper
• Factores de riesgo para los tumores hepáticos malignos pediátricos

  2008cites this paper
• Tumores neonatales y malformaciones congénitas

  2008cites this paper
• Predicting the Performance of a Genetic Testing Service for Cancer Susceptibility

  2007cites this paper
• Trends in childhood cancer incidence: review of environmental linkages.

  2007cites this paper
• Malignant adrenal tumors.

  2006cites this paper
• Factores de riesgo para los tumores óseos malignos pediátricos

  2005cites this paper